Surgical Management of Villous Tumors of the Colon and Rectum

Malafosse, M; Roge, P.

doi:10.1159/000171646

Cited by 6 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…But complications and recurrences are also reported after surgery. The complication rate was 21% in two large series [22,23] including a 2.5'%, death rate. The recurrence rates after surgery range from 3.6% to 42% [22-251, the highest rates occurring after transanal surgery.…”

Section: Discussionmentioning

confidence: 88%

Lasers in Rectosigmoid Tumors

Brunetaud¹,

Maunoury²,

Cochelard³

et al. 1990

Medical Laser Endoscopy

View full text Add to dashboard Cite

Over a 14-year period, 746 patients were treated at the Lille Laser Center for rectosigmoid tumor. Two hundred seventy-two patients were treated for palliation of symptoms from rectosigmoid cancer and 474 patients were treated for a benign rectosigmoid villous adenoma. The immediate success rate and complication rate were 85% and 2%, respectively, for patients with advanced cancer, and 92.8% and 1.8% for those with a villous adenoma. Patients with an advanced cancer remained functionally improved during a 10.1 -month average period after initial improvement. The recurrence rate after initial treatment for villous adenomas was 18% during a 29.7-month average follow-up. Immediate results were influenced by reason for treatment, initial symptoms, and circumferential extension for patients with a cancer, and only by circumferential extension for patients with a villous adenoma. Long-term results were influenced by reason for treatment and circumferential extension for patients with cancer, and by reason for treatment, initial histology and localization for patients with a villous adenoma. Laser treatment provided relief of symptoms in inoperable patients with advanced rectosigmoid carcinomas. Because treatment is long and difficult and the cancer rate is high, endoscopic laser should be limited in patients with a circumferential villous adenoma to nonsurgical candidates. The risk of complication after surgery (some being fatal) has to be balanced against the risk of undetected carcinoma and the indication for endoscopic laser treatment should be discussed case by case.

show abstract

Section: Discussionmentioning

confidence: 88%

Lasers in Rectosigmoid Tumors

Brunetaud¹,

Maunoury²,

Cochelard³

et al. 1990

Medical Laser Endoscopy

View full text Add to dashboard Cite

show abstract

Lasers in rectosigmoid tumors

Brunetaud

Maunoury

Cochelard³

1995

Seminars in Surgical Oncology

View full text Add to dashboard Cite

Over a 14-year period, 746 patients were treated at the Lille Laser Center for rectosigmoid tumor. Two hundred seventy-two patients were treated for palliation of symptoms from rectosigmoid cancer and 474 patients were treated for a benign rectosigmoid villous adenoma. The immediate success rate and complication rate were 85% and 2%, respectively, for patients with advanced cancer, and 92.8% and 1.8% for those with a villous adenoma. Patients with an advanced cancer remained functionally improved during a 10.1-month average period after initial improvement. The recurrence rate after initial treatment for villous adenomas was 18% during a 29.7-month average follow-up. Immediate results were influenced by reason for treatment, initial symptoms, and circumferential extension for patients with a cancer, and only by circumferential extension for patients with a villous adenoma. Long-term results were influenced by reason for treatment and circumferential extension for patients with cancer, and by reason for treatment, initial histology and localization for patients with a villous adenoma. Laser treatment provided relief of symptoms in inoperable patients with advanced rectosigmoid carcinomas. Because treatment is long and difficult and the cancer rate is high, endoscopic laser should be limited in patients with a circumferential villous adenoma to non-surgical candidates. The risk of complication after surgery (some being fatal) has to be balanced against the risk of undetected carcinoma and the indication for endoscopic laser treatment should be discussed case by case.

show abstract